← Eichor
Study identifier: NCT03663361 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Addressing Neuromuscular Deficits for Improved Outcomes in Ankle Rehabilitation

Condition: Ankle Sprains  ·  Sponsor: Phillip Gribble

PhaseNA
Planned participants150
Who can joinAll sexes, 18 Years to 44 Years
Healthy volunteersNo

About this study

The purpose of this project is to compare a novel sensorimotor ankle rehabilitation training (SMART) protocol for Lateral ankle sprains (LASs) against a standard of care (SOC) protocol to determine if it is more successful at producing successful one-year outcomes and lower rates of re-injury and improved health. This will address the identified needs for evidence-support and reintegration strategies to improve understanding of the management of patient rehabilitation strategies throughout the rehabilitation process following neuromusculoskeletal injury. The project will validate an innovative rehabilitation approach while providing metrics of success using a variety of clinical and innovative markers.

This description comes directly from the study's public registry record.

Talk to the study team

Kyle Kosik, PhD  ·  859-323-9850  ·  kyle.kosik@uky.edu

Always discuss trial participation with your own doctor first.

Locations (2)

University of KentuckyLexington, Kentucky, United StatesRecruiting
University of North Carolina at Chapel HillChapel Hill, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03663361